Company Filing History:
Years Active: 2019
Title: David James Gould: Innovator in Fusion Protein Technology
Introduction
David James Gould is a notable inventor based in London, GB. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. His innovative work has led to the creation of a patent that addresses important medical applications.
Latest Patents
David holds a patent for a "Modified latency associated protein construct." This invention provides a fusion protein that comprises a latency associated peptide (LAP), a pharmaceutically active agent, and an amino acid sequence that includes a dimerization domain. The LAP and the pharmaceutically active agent are connected by an amino acid sequence that features a proteolytic cleavage site. Additionally, the patent includes nucleic acids enclosing such fusion proteins, processes for their preparation, pharmaceutical compositions, kits, and their uses in medicine.
Career Highlights
David is currently associated with Stealthyx Therapeutics Limited, where he continues to advance his research and development efforts. His work focuses on innovative solutions that can potentially transform therapeutic approaches in medicine.
Collaborations
David collaborates with talented individuals such as Yuti Chernajovsky and Lisa Mullen, who contribute to the success of his projects and research initiatives.
Conclusion
David James Gould is a prominent figure in the field of biotechnology, with a patent that showcases his innovative approach to fusion protein technology. His contributions have the potential to impact medical science significantly.